FDA Refuses To Review Moderna’s Flu Vaccine
Digest more
By Siddhi Mahatole and Gnaneshwar Rajan Feb 11 (Reuters) - The United States will take part in a World Health Organization meeting at the end of the month to determine the composition of upcoming influenza vaccines,
Refusal to review the submission is inconsistent with feedback at pre-Phase 3 and pre-submission consultations; Moderna
Flu season is not over yet, experts warn. Is there a second wave coming? Here's how to protect yourself as influenza keeps spreading.
The U.S. will participate in the World Health Organization’s (WHO) upcoming meeting on the composition of the influenza vaccine despite officially withdrawing from the global group last month. The WHO will meet on Feb.
America’s drug safety agency declined to review a next-gen flu vaccine that uses the same tech as the coronavirus shots
Feb 11 (Reuters) - The United States will participate in a World Health Organization meeting at the end of the month to determine the composition of upcoming influenza vaccines, the agency's official said at a press conference on Wednesday.
As one variant of the flu virus starts to decline, another is rising to take its place.
This influenza season has not offered much of a reprieve from last season, which ranks as one of the worst in the past 20 years, according to the CDC. Across the United States, the CDC estimates there have been at least 22 million illnesses,
Mount Sinai researchers have identified a cellular mechanism linking infections from influenza A viruses (IAVs) to cardiovascular disease, providing critical insights on how influenza can damage the heart and increase the risk of a heart attack or other major cardiovascular event.